Rankings
▼
Calendar
XOMAP FY 2022 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena
XOMAP
XOMA Corporation
$311M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
-84.2% YoY
Gross Profit
$6M
95.5% margin
Operating Income
-$17M
-288.9% margin
Net Income
-$17M
-283.8% margin
EPS (Diluted)
$-1.98
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$28M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$140M
Total Liabilities
$16M
Stockholders' Equity
$124M
Cash & Equivalents
$58M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6M
$38M
-84.2%
Gross Profit
$6M
$38M
-84.9%
Operating Income
-$17M
$18M
-199.3%
Net Income
-$17M
$16M
-208.3%
← Q4 2021
All Quarters
Q1 2022 →